175 related articles for article (PubMed ID: 36588564)
1. Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy.
Dillon HT; Foulkes S; Horne-Okano YA; Kliman D; Dunstan DW; Daly RM; Fraser SF; Avery S; Kingwell BA; La Gerche A; Howden EJ
Front Cardiovasc Med; 2022; 9():926064. PubMed ID: 36588564
[TBL] [Abstract][Full Text] [Related]
2. Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors.
Dillon HT; Foulkes S; Horne-Okano YA; Kliman D; Dunstan DW; Daly RM; Fraser SF; Avery S; Kingwell BA; La Gerche A; Howden EJ
Sci Rep; 2023 Feb; 13(1):2112. PubMed ID: 36747066
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.
Armenian SH; Horak D; Scott JM; Mills G; Siyahian A; Berano Teh J; Douglas PS; Forman SJ; Bhatia S; Jones LW
Biol Blood Marrow Transplant; 2017 Apr; 23(4):700-705. PubMed ID: 28065839
[TBL] [Abstract][Full Text] [Related]
4. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol.
Dillon HT; Saner NJ; Ilsley T; Kliman D; Spencer A; Avery S; Dunstan DW; Daly RM; Fraser SF; Owen N; Lynch BM; Kingwell BA; La Gerche A; Howden EJ
BMC Cancer; 2022 Aug; 22(1):898. PubMed ID: 35978289
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.
Massey RJ; Diep PP; Ruud E; Burman MM; Kvaslerud AB; Brinch L; Aakhus S; Gullestad LL; Beitnes JO
JACC CardioOncol; 2020 Sep; 2(3):460-471. PubMed ID: 34396253
[TBL] [Abstract][Full Text] [Related]
6. Reduced exercise capacity is associated with left ventricular systolic dysfunction in long-term survivors of allogeneic hematopoietic stem-cell transplantation.
Massey RJ; Myrdal OH; Diep PP; Burman MM; Brinch L; Gullestad LL; Ruud E; Aakhus S; Beitnes JO
J Clin Ultrasound; 2023 Jan; 51(1):5-15. PubMed ID: 35788941
[TBL] [Abstract][Full Text] [Related]
7. Traditional markers of cardiac toxicity fail to detect marked reductions in cardiorespiratory fitness among cancer patients undergoing anti-cancer treatment.
Howden EJ; Foulkes S; Dillon HT; Bigaran A; Wright L; Janssens K; Comie P; Costello B; La Gerche A
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):451-458. PubMed ID: 33543256
[TBL] [Abstract][Full Text] [Related]
8. Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
Myrdal OH; Diep PP; Ruud E; Brinch L; Massey RJ; Edvardsen E; Kongerud J; Lund MB; Sikkeland LI
Support Care Cancer; 2021 Apr; 29(4):1959-1967. PubMed ID: 32827056
[TBL] [Abstract][Full Text] [Related]
9. Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy.
Bonsignore A; Marwick TH; Adams SC; Thampinathan B; Somerset E; Amir E; Walker M; Abdel-Qadir H; Koch CA; Ross HJ; Woo A; Wintersperger BJ; Haykowsky MJ; Thavendiranathan P
JACC CardioOncol; 2021 Dec; 3(5):678-691. PubMed ID: 34988476
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
11. Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Klyuchnikov E; Bacher U; Kröger NM; Hari PN; Ahn KW; Carreras J; Bachanova V; Bashey A; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Hertzberg MS; Holmberg LA; Kharfan-Dabaja MA; Klein A; Ku GH; Laport GG; Lazarus HM; Miller AM; Mussetti A; Olsson RF; Slavin S; Usmani SZ; Vij R; Wood WA; Maloney DG; Sureda AM; Smith SM; Hamadani M
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2091-2099. PubMed ID: 26253007
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
13. Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.
Khouri MG; Hornsby WE; Risum N; Velazquez EJ; Thomas S; Lane A; Scott JM; Koelwyn GJ; Herndon JE; Mackey JR; Douglas PS; Jones LW
Breast Cancer Res Treat; 2014 Feb; 143(3):531-9. PubMed ID: 24390149
[TBL] [Abstract][Full Text] [Related]
14. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
Huang A; Cicin-Sain C; Pasin C; Epp S; Audigé A; Müller NJ; Nilsson J; Bankova A; Wolfensberger N; Vilinovszki O; Nair G; Hockl P; Schanz U; Kouyos RD; Hasse B; Zinkernagel AS; Trkola A; Manz MG; Abela IA; Müller AMS
Transplant Cell Ther; 2022 Apr; 28(4):214.e1-214.e11. PubMed ID: 35092892
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
17. Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer.
Yu AF; Flynn JR; Moskowitz CS; Scott JM; Oeffinger KC; Dang CT; Liu JE; Jones LW; Steingart RM
JAMA Cardiol; 2020 Mar; 5(3):309-317. PubMed ID: 31939997
[TBL] [Abstract][Full Text] [Related]
18. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
19. [The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field].
Nakamae M
Rinsho Byori; 2017 Mar; 65(3):331-338. PubMed ID: 30802020
[TBL] [Abstract][Full Text] [Related]
20. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
